Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer

Gemcitabine plus nab-paclitaxel is the current standard chemotherapy for patients with metastatic pancreatic cancer. We conducted a phase I/II study in Japan, in which high response rates and manageable toxicity were observed. In this study, two patients were reported as experiencing pancreatitis du...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Makoto, Nagashima, Fumio, Ueno, Hideki, Ikeda, Masafumi, Ohkawa, Shinichi, Mizuno, Nobumasa, Ioka, Tatsuya, Omuro, Yasushi, Nakajima, Takako Eguchi, Furuse, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859393/
https://www.ncbi.nlm.nih.gov/pubmed/31243233
http://dx.doi.org/10.2169/internalmedicine.2362-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859393/
https://www.ncbi.nlm.nih.gov/pubmed/31243233
http://dx.doi.org/10.2169/internalmedicine.2362-18

Ejemplares similares